Elevated WC is a clear marker of increased cardiometabolic risk and may add to the assessment of a patient’s risk profile in the clinical setting. Therapeutic lifestyle changes can reduce both visceral adiposity and insulin resistance and may positively affect all aspects of the metabolic syndrome and reduce cardiometabolic risk. Lifestyle change and metformin
therapy have both been shown to halt progression from insulin resistance to T2DM,